Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stelios Bouralexis
Observed names:
S Bouralexis,
S. Bouralexis
Institution:
St Vincents Institute of Medical Research
Observed institutions:
Royal Adelaide Hospital,
Hanson Institute,
Adelaide University,
The University of Adelaide,
St Vincents Institute of Medical Research
OpenAlex ID:
A5110153590
Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors
2000
·
Gerald J. Atkins
, David R. Haynes
, et al.
·
Journal of Bone and Mineral Research
·
204
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis
2002
·
Andreas Evdokiou
, Stelios Bouralexis
, et al.
·
International Journal of Cancer
·
141
PDF
Death to the bad guys: Targeting cancer via Apo2L/TRAIL
2005
·
S. Bouralexis
, D. M. Findlay
, et al.
·
APOPTOSIS
·
136
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone
2001
·
G.J Atkins
, S Bouralexis
, et al.
·
Bone
·
110
IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
2008
·
Julian M W Quinn
, Natalie A Sims
, et al.
·
The Journal of Immunology
·
102
PDF
Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis
2003
·
A Evdokiou
, A Labrinidis
, et al.
·
Bone
·
81
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
2003
·
S Bouralexis
, D M Findlay
, et al.
·
British Journal of Cancer
·
80
PDF
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
2006
·
Lisa M. Butler
, Vasilios Liapis
, et al.
·
International Journal of Cancer
·
75
PDF
Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis
2002
·
G.J Atkins
, S Bouralexis
, et al.
·
Bone
·
67
Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro
2007
·
Akira Nakamura
, Chi Ly
, et al.
·
Bone
·
37
Enhanced Apoptosis of Soft Tissue Sarcoma Cells with Chemotherapy: A Potential New Approach Using Trail
2001
·
M Clayer
, S Bouralexis
, et al.
·
Journal of orthopaedic surgery
·
25
PDF
Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism
2002
·
DM Findlay
, LJ Raggatt
, et al.
·
Journal of Endocrinology
·
23
PDF
Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin
2004
·
S. Bouralexis
, M. Clayer
, et al.
·
International Journal of Oncology
·
18
Molecular mechanisms of Apo2L/TRAIL induced apoptosis in normal and malignant cells / by Stelios Bouralexis.
2003
·
Stelios Bouralexis
·
Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Zoledronate is anabolic for human osteoblast-like cells
2002
·
Gerald J. Atkins
, Baolong Pan
, et al.
·
Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Protection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosis
2001
·
D. Findlay
, Stelios Bouralexis
, et al.
·
Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosis
2001
·
Gerald J. Atkins
, Andreas Evdokiou
, et al.
Show more works
View as search
Works count:
17
Citation count:
1,099
H-index:
13
I10-index:
13
Year
Topic
Type